A CASE SERIES OF RHEUMATIC DISEASE PATIENTS DIAGNOSED WITH COVID-19 FEB 2020 TO MARCH 2021 AT THE HOSPITAL THAT REPORTED LONDON'S INDEX CASE OF COVID-19
Rheumatology (United Kingdom)
; 61(SUPPL 1):i55, 2022.
Article
in English
| EMBASE | ID: covidwho-1868382
disease modifying antirheumatic drug; hydroxychloroquine; methotrexate; steroid; vaccine; adult; aged; ankylosing spondylitis; case report; case study; Caucasian; clinical article; cohort analysis; comorbidity; conference abstract; coronavirus disease 2019; demographics; drug therapy; electronic medical record system; England; ethnicity; female; gender; Hispanic; hospital admission; hospital patient; hospitalization; human; male; middle aged; morbidity; mortality; mortality rate; outcome assessment; outpatient; people by smoking status; psoriatic arthritis; retrospective study; rheumatic disease; rheumatoid arthritis; rheumatology; risk factor; Sjoegren syndrome; systemic lupus erythematosus; teleconsultation
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Long Covid
/
Vaccines
Language:
English
Journal:
Rheumatology (United Kingdom)
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS